|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 10332 studies with search of: | cancer | Open Studies |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer
|
||||
| 2 | Recruiting |
Screening Methods for Finding Ovarian Cancer
|
||||
| 3 | Recruiting |
Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer or Polyposis Syndrome or Who Are at High Risk of Developing Hereditary Colorectal Cancer
|
||||
| 4 | Recruiting |
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
|
||||
| 5 | Recruiting |
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
|
||||
| 6 | Recruiting |
GM-CSF and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin
|
||||
| 7 | Recruiting |
Reducing Cancer Disparities for American Indians in the Rural Intermountain West
|
||||
| 8 | Recruiting |
Estrogen, Diet, Genetics and Endometrial Cancer
|
||||
| 9 | Recruiting |
AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or Ovarian Epithelial Cancer
|
||||
| 10 | Recruiting |
Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Liver Cancer, Islet Cell Cancer, or Carcinoid Tumor
|
||||
| 11 | Recruiting |
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
|
||||
| 12 | Recruiting |
AG014699 in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
|
||||
| 13 | Recruiting |
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed in Treating Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or Other Solid Tumors
|
||||
| 14 | Recruiting |
Erlotinib and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
|
||||
| 15 | Recruiting |
Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
|
||||
| 16 | Recruiting |
Psychosocial Adjustment After Radiation Therapy in Patients With Breast Cancer, Colorectal Cancer, Lung Cancer, or Prostate Cancer
|
||||
| 17 | Recruiting |
AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
|
||||
| 18 | Recruiting |
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
|
||||
| 19 | Recruiting |
ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
|
||||
| 20 | Recruiting |
Aspirin in Treating Patients With Dukes Stage C Colon or Rectal Cancer, Dukes Stage B Rectal Cancer, or High-Risk Dukes Stage B Colon Cancer That Has Been Completely Removed by Surgery
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|